We set our sight at 2 years, but after only 20 months since the launch of FACADE-trial, we have reached our recruitment target on Feb 12th and just two days ago operated on this very last patient.
All 104 trial participants have now either entered or completed the follow-up phase and we are expecting to start working on the data in September 2021. The entire FAÇADE study group has been extremely devoted to the trial, so huge thanks to all members already at this point!
Eagerly looking forward to September and data analysis!
